Drug intelligence / Profile preview

hexahydrocurcumin

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral, Ophthalmic
01

Overview

Hexahydrocurcumin is a natural diarylheptanoid compound and a major active metabolite of curcumin. It is found in plants such as Zingiber officinale (ginger). Hexahydrocurcumin acts as a selective and orally active cyclooxygenase-2 (COX-2) inhibitor with no significant activity against COX-1. It exhibits potent antioxidant, anti-inflammatory, and anticancer properties. Mechanistically, it reduces prostaglandin E2 production by downregulating COX‑2 expression and modulates oxidative stress pathways by activating nuclear factor erythroid 2-related factor 2 (NRF2), enhancing cellular antioxidant defenses. Preclinical studies suggest potential therapeutic applications in cancer (notably colon and breast cancer), retinal degenerative diseases such as age-related macular degeneration (AMD), and other conditions associated with inflammation or oxidative stress[1][3][4][5][7][8][10].

Other names
5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)heptan-3-onecurcumin, hexahydro-3-heptanone, 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-HHC
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on hexahydrocurcumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hexahydrocurcumin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call